Morning Buzz: Achillion Pharmaceuticals (ACHN), Enanta Pharmaceuticals (ENTA), NewLink Genetics (NLNK), Apple (AAPL), Taser (TASR)

Shares of Achillion Pharmaceuticals, Inc. (ACHN) are up 14% in pre-market trading Monday after the company announced positive results from two studies supporting a short duration, potentially best-in-disease regimen of its proprietary NS5A and nucleotide inhibitors, ACH-3102 and ACH-3422. “We believe that achievement of 100 percent SVR4 in six weeks in the ACH-3102 proxy study, […] View the full post at: Morning Buzz: Achillion Pharmaceuticals (ACHN), Enanta Pharmaceuticals (ENTA), NewLink Genetics (NLNK), Apple (AAPL), Taser (TASR) Related posts: Harbinger Discloses 9.48% Stake in Palm (PALM) iPhone Going to Russia